In Mali, West Africa, the International Centers for Excellence in Research (ICER) program was established based on experience gained from NIAID long-standing malaria research collaboration with Malian scientists, academic leadership, and the Malian government. Malaria researchers from the NIAID Division of Intramural Research initiated a collaboration focused on malaria entomology in 1989 with counterparts at the National School of Medicine and Pharmacy in Bamako. At the time, Mali was selected as an ideal site for collaboration because of a recognized team of Malian researchers already working on the genetics and cytogenetics of Anopheles gambiae, the primary vector of malaria in sub-Saharan Africa. Shortly thereafter, the Malaria Research and Training Center (MRTC) was established at the National School of Medicine and Pharmacy to facilitate research in collaboration with NIAID and other international partners.
The research laboratories and support facilities at the National School of Medicine and Pharmacy (which became the Faculty of Medicine, Pharmacy and Oral Surgery in 1995 when the University of Mali was founded) were expanded significantly in the early 1990s with support from NIAID and other international partners. The scope of research activities was further expanded in subsequent years to include other aspects of malaria research and research on other parasitic and viral diseases. Since 2002 when the ICER was established in Mali, the MRTC has continued as a Malian entity affiliated, as are other research program entities, with the NIAID-supported ICER.
In 2008, intramural scientists from the NIAID Rocky Mountain Laboratories (RML) in Montana initiated studies on arthropod vectors and animal reservoirs that transmit relapsing fever. In 2009, RML scientists and their Malian collaborators confirmed the presence of Lassa virus in Mali. These scientific teams are now developing a research program to screen for and study other hemorrhagic fever viruses in the country. As part of its program in Mali, NIAID has provided significant training opportunities to young Malians both in- country as well as at the National Institutes of Health (NIH).
Detailed Information on Mali ICER Cooperative Research Programs and Facilities
Medical Entomology Program
- Molecular Entomology
- Molecular Ecology
- GIS/Remote Sensing
- Vector Proteomics
- Vector Bioinformatics
- Malaria Immunology
- Malaria Pathogenesis
- Lassa fever
- Relapsing fever
Parasitology/Vaccine Development Program
- Vaccine trial data center
- Vaccine trial field sites
- Drug research
- Insecticide resistance
- BSL-3 TB laboratory
- HIV/TB laboratories
- Library/conference room Lunch room
- Freezer room
- Motor pool storage facilities (laboratory supplies)
- Guest house, with dining facility, computer room
- Administrative offices
- Emergency power system
- VSAT communication satellite system with links to the internal NIH IT systems and to study sites in remote villages
- Video conference rooms
- Core immunology laboratory
- CAP-accredited clinical laboratory
The Mali ICER maintains several field and clinical research sites throughout the country, including sites for field testing of candidate vaccines and drug testing. The center has conducted major studies in Mopti, Koro, Niono, Bandiagara, Bancoumana, Sotuba, Donegebougou, Kenieroba, Tienegoubougou, Kambila, Kalifabougou, Ouelessebougou, and Thierola.
The current staff consists of approximately 220 researchers, administrative staff, support personnel, and students. All Malian staff members are supported through a contract with the USTTB. Of special note, the center hosts several senior Malian medical, pharmacy, and biology students, as well as students from neighboring African countries who are conducting hands-on research for their M.D., Pharm.D., and Ph.D. theses.
NIH-supported programs are overseen by two American direct hires: a resident scientist who manages day to day scientific operations; as well as a country representative and director of the NIAID/NIH Mali Office, who administers programs and serves as a liaison between the U.S. and Malian government and non-government entities.
Ongoing NIH-Funded Projects (2014)
Following are summaries of the various NIH-funded projects currently being conducted at the Mali ICER.
|Project Name||Dates||Study Site(s)||Ongoing Protocol(s)|
|Malaria Vector Ecology||2004 to present||Thierola and surrounding villages||Studies all aspects of malaria vector ecology with the aim of uncovering ecological factors which may be exploited to help control malaria transmission.|
|Malaria Transmission Assay Development and Gametocyte Carriage (Pfs25 vaccine trial)||2011 to present||Bancoumana||Development of an assay to evaluate the potential of a candidate malaria transmission-blocking vaccine.|
|Immuno-Epidemiology||2011 to present||Ouelessebougou||A study of host and parasite factors that influence susceptibility to malarial infection and disease during pregnancy and early childhood.|
|Lymphatic Filariasis||2004 to present||Tieneguebougou||Study of mass drug administration, assessment of new drugs and treatment strategies, and co-infections with malaria.|
|Longitudinal Study of Healthy Volunteers to Determine if Malaria Resistance is Associated with Acquisition of Specific Memory B-Cells||2010 to present||Kambila||A study designed to test the hypothesis that resistance to malaria is associated with the acquisition of B memory cells specific to P. falciparum.|
|Lassa Fever, relapsing fever and Crimean-Congo hemorrhagic fever||2009 to present||Soromba and surrounding villages||Study to map the prevalence of these diseases in Mali by analyzing tick and rodent reservoirs.|
|Longitudinal Systems Biological Analysis of Naturally-Acquired Malaria Immunity||2011 to present||Kalifabougou||Identify gene expression profiles induced byP. falciparum infections associated with malaria immunity|
|Leishmaniasis||2004 to present||Baraoueli||Surveillance of cutaneous leishmaniasis vector studies and vaccine development|
|Tick-borne Relapsing Fever in Mali||2009 to present||Multiple sites||Surveillance of various sites in Mali for tick-borne relapsing fever, vector studies and isolation of the parasite.|
|Activated Charcoal study||2013 to present||Kenerioba||Open labeled randomized controlled trial to test a novel therapeutic intervention that aims at reducing the morbidity caused by severe malaria infection in children using charcoal tabs.|
|PfSPZ vaccine trial||2014 to present||Doneguebougou||Double blind, randomized controlled trial evaluating the safety and immunogenicity of a novel malaria vaccine candidate in Malian adults.|
|SEREFO||2004 to present||Multiple sites||
Study to assess the relationship of co-infection with HIV and tuberculosis
|International Centers of Excellence for Malaria Research (ICEMR)||2010 to present||Multiple sites in Mali, Senegal, and Gambia||
Studies aimed to characterize and understand
|Tropical Medicine Research Centers (TMRC)||2012 to present||Multiple sites in Mali and Ghana||Study of cutaneous leishmaniasis and filariasis co-infections in West-Africa|
|Malaria Bandiagara Project||2005 to Present||Bandiagara||Study of the genetic diversity and protective immunity to malaria infection and disease|
|President’s Malaria Initiative Collaborations with USAID|
|IRS Monitoring in 3 District Sentinel Site||2008 to present||Bla, Koulikoro, and Baraoueli||Monitoring of vector populations, biting behavior, malaria transmission dynamics and determining insecticide resistance status.|
|Strengthening National Malaria Control Capability in Case Management||2008 to present||Multiple sites||Training health workers in malaria diagnostics (microscopy and RDT) and malaria surveillance trough case management.|